WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) have finalized a licensing agreement with the Spanish National Research Council (CSIC) for a COVID-19 serological antibody technology. The test effectively checks for the presence of anti-SARS-CoV-2 antibodies developed either in response to a COVID-19 infection or to a vaccine. This represents the […]

The U.S. FDA has approved Takeda Pharmaceuticals’ Livtencity (maribavir) as the first drug for treating adults and paediatric patients (12 years of age and older and weighing at least 35 kilograms) with post-transplant cytomegalovirus (CMV) infection that does not respond to available antiviral treatment for CMV. Livtencity works by preventing the activity of human cytomegalovirus […]

The United States Centers for Disease Control and Prevention (CDC) will invest $26 million in funding to develop next-generation infectious disease forecasting and analytics. The agency will provide $21 million to support research and development of advanced infectious disease models and analytical tools. The awards will support three years of work at five leading academic […]

Canon Medical Systems and Resoundant have signed a licensing agreement for the purpose of incorporating the advanced Magnetic Resonance Elastography (MRE), developed by Resoundant on the Canon MRI platforms. Canon Medical and Resoundant have been working closely together to implement a seamless integration of the latest MRE technology on Canon’s newest line of MRI scanners.